FEMY Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	62 179.00
Gjennomsnittsvolum	717 382
Markedsverdi	28.66M
EPS	$0 ( 2024-04-04 )
Neste inntjeningsdato	( $-0.220 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.390
ATR14	$0.00600 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-12	Spector Richard D.	Buy	100 000	Stock Option (Right to Buy)
2024-02-12	Spector Richard D.	Buy	0
2024-02-01	Currie Daniel Scott	Buy	61 900	Stock Option (Right to Buy)
2024-02-01	Elefant Dov	Buy	84 000	Stock Option (Right to Buy)
2024-02-01	Thomas Christine E	Buy	32 600	Stock Option (Right to Buy)

INSIDER POWER
-78.98
Last 82 transactions
Buy: 6 908 475 \| Sell: 19 734 221

Volum Korrelasjon

Lang: -0.10 (neutral)

Kort: -0.82 (strong negative)

Signal:(61.791) Neutral

Femasys Inc. Korrelasjon

10 Mest positive korrelasjoner
POWL	0.929
VEON	0.922
ALRM	0.917
OCUL	0.917
IOVA	0.916
CLBT	0.915
TARA	0.91
PXLW	0.906
QRTEA	0.905
PEPG	0.905

10 Mest negative korrelasjoner
DCRC	-0.919
SGLB	-0.904
CYAN	-0.873
SSRM	-0.868
DSWL	-0.859
GIGM	-0.859
BLKB	-0.858
GRNA	-0.855
DSPC	-0.85
WTER	-0.846

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Femasys Inc. Korrelasjon - Valuta/Råvare

0.19
( neutral )

-0.30
( neutral )

0.00
( neutral )

0.66
( moderate )

Femasys Inc. Økonomi

Annual	2023
Omsetning:	$1.07M
Bruttogevinst:	$-216 084 (-20.16 %)
EPS:	$-0.930

FY	2023
Omsetning:	$1.07M
Bruttogevinst:	$-216 084 (-20.16 %)
EPS:	$-0.930

FY	2022
Omsetning:	$1.21M
Bruttogevinst:	$764 280 (63.36 %)
EPS:	$-0.970

FY	2021
Omsetning:	$1.18M
Bruttogevinst:	$809 305 (68.60 %)
EPS:	$-0.831

Financial Reports:

No articles found.

Femasys Inc.

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

Sanntidsoppdatering for Femasys Inc. [FEMY]

Upcoming Earnings Alert